Jump to section
Infermedica's mission is to is to make healthcare accessible, convenient and affordable by automating primary care, from symptom to outcome.
37% employee growth in 12 months
AI-powered symptom checkers have undergone something of a renaissance over the past decade. Infermedica, an AI-powered medical guidance platform, offers solutions for symptom analysis and patient triage that helps insurers, telemedicine companies and health systems increase efficiency through fast, digital symptom-checks.
The platform is designed to support all processes from symptom onset to resolution, encompassing pre-visit, visit and post-visit tools. Capabilities include triage recommendation for patients, health summaries and automated notes, and treatment plan follow-ups and check-ups. It has also recently introduced an expansion of its API to include Intake functionalities.
With a number of clients in the healthcare space - including Gothaer, Cigna, and Optum - Infermedica now spans 30 countries and has completed more than 10 million patient interviews. It is well-funded, investing its 2022 Series B into expanding its Medical Guidance Platform and adding new modules to cover the full primary care journey.
Steph
Company Specialist at Welcome to the Jungle
Jan 2022
$30m
SERIES B
Aug 2020
$9.3m
SERIES A
This company has top investors
Piotr Orzechowski
(CEO)Former CTO at Sky Storage and co-founder of software company QCode.
Irving Loh
(Chief Medical Officer)Medical doctor, lecturer at Stanford University School of Medicine, and Board Member of multiple cardiology and medicine organisations.